PNC
45
4
URBN
67
-3
BAC
47
5
GM
65
4
TGT
45
3
BXP
46
4
ACN
42
-16
M
31
4
SPG
61
8
EXC
50
3
PBI
32
2
MA
67
2
WAT
32
-4
R
63
3
SBUX
33
-2
NAVI
38
2
ALLE
35
10
CVX
25
3
INTU
66
-3
GWW
44
-2
PNC
45
4
URBN
67
-3
BAC
47
5
GM
65
4
TGT
45
3
BXP
46
4
ACN
42
-16
M
31
4
SPG
61
8
EXC
50
3
PBI
32
2
MA
67
2
WAT
32
-4
R
63
3
SBUX
33
-2
NAVI
38
2
ALLE
35
10
CVX
25
3
INTU
66
-3
GWW
44
-2
Financhill
Back

MoneyLion Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

ML
MoneyLion

Last Price:
72.72
Seasonality Move:
23.66%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
46
MoneyLion (ML) is a Sell

Is MoneyLion a Buy, Sell or Hold?

  • The current MoneyLion [ML] share price is $71.89. The Score for ML is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ML is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ML Stock Price Chart

What is MoneyLion's stock price today?

  • The MoneyLion share price today is $71.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ML is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ML Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.75 Sell
Relative Strength Index (14 RSI): 36.97 Sell
Chaikin Money Flow: -94166 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.35 - 94.33) Sell
Bollinger Bands (100): (55.26 - 84.32) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

ML Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.55 Sell
20-day SMA: 87.51 Sell
50-day SMA: 79.73 Sell
200-day SMA: 52.82 Buy
8-day EMA: 78.5 Sell
20-day EMA: 82.39 Sell
50-day EMA: 79.61 Sell
200-day EMA: 58.56 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

MoneyLion Earnings Growth & ML Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.97 per share, and an increase next year of $3.35 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

MoneyLion Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):